These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31439551)

  • 1. Life-threatening bleeding due to persistent dabigatran effect in a patient with sepsis despite idarucizumab therapy and haemodialysis.
    Humphries K; Huggan P; Stiles M; Martynoga R
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31439551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Dabigatran-Associated Bleeding with Two Doses of Idarucizumab Plus Hemodialysis.
    Marino KK; Santiago RA; Dew RB; Berliner N; Connors JM; Connell NT; Tucker JK
    Pharmacotherapy; 2016 Oct; 36(10):e160-e165. PubMed ID: 27581709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran.
    Simon A; Domanovits H; Ay C; Sengoelge G; Levy JH; Spiel AO
    J Thromb Haemost; 2017 Jul; 15(7):1317-1321. PubMed ID: 28426914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Severe dabigatran intoxication complicated by insufficient reversal by idarucizumab].
    Hellfritzsch M; Hvas AM
    Ugeskr Laeger; 2020 Apr; 182(15):. PubMed ID: 32286218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent life-threatening hemorrhage after administration of idarucizumab.
    Alhashem HM; Avendano C; Hayes BD; Winters ME
    Am J Emerg Med; 2017 Jan; 35(1):193.e3-193.e5. PubMed ID: 27439386
    [No Abstract]   [Full Text] [Related]  

  • 6. [The first use of iv. idarucizumab for dabigatran reversal in Hungary].
    Driesz L; Barabás É; Bodócs I; Szántó Z; Herr G; Bencsik G; Pál L; Borbola J
    Orv Hetil; 2017 Mar; 158(10):387-392. PubMed ID: 28270004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of gastrointestinal bleeding with idarucizumab in a patient receiving dabigatran.
    Mourafetis J; Doctor N; Leung S
    Am J Health Syst Pharm; 2018 Feb; 75(4):177-182. PubMed ID: 29343478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report.
    Agosti S; Casalino L; Rocci E; Zaccone G; Rota E
    J Med Case Rep; 2017 Aug; 11(1):224. PubMed ID: 28806993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dabigatran Reversal With Idarucizumab Preceding Thrombolysis in an Octogenarian Patient with Chronic Kidney Disease and Acute Stroke: A Case Report.
    Laxamana LC; Co COC; Yu JRT; Mojica CV; Iboleon-Dy MAM; Domingo AMC; Ilano KCS; Macrohon-Valdez MCZ
    Clin Ther; 2020 Sep; 42(9):1840-1845. PubMed ID: 32778345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory Dabigatran-Induced Hemorrhage Despite Multiple Idarucizumab Administration and Renal Replacement Therapy.
    Flynn F; Richard G; Dobrescu MA; Bouchard J; Williamson D; Brindamour D; Charbonney E; Dupuis S
    J Pharm Pract; 2022 Apr; 35(2):302-307. PubMed ID: 32985337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare presentation of necrotising fasciitis and streptococcal toxic shock syndrome by group A streptococcus.
    Saeed S; Alothman S; Ahmed L; Donaldson B
    BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28954758
    [No Abstract]   [Full Text] [Related]  

  • 12. Idarucizumab for Reversal of Dabigatran Prior to Acute Surgery: A Schematic Approach Based on a Case Report.
    Rosenberg L; Gerstrøm G; Nybo M
    Basic Clin Pharmacol Toxicol; 2017 Apr; 120(4):407-410. PubMed ID: 27797449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idarucizumab administration for reversing dabigatran effect in an acute kidney injured patient with bleeding.
    Quintard H; Viard D; Drici MD; Ruetsch C; Samama CM; Ichai C
    Thromb Haemost; 2017 Jan; 117(1):196-197. PubMed ID: 27734073
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombolytic Therapy in Severe Cardioembolic Stroke After Reversal of Dabigatran with Idarucizumab: Case Report and Literature Review.
    Ohya Y; Makihara N; Wakisaka K; Morita T; Ago T; Kitazono T; Takaba H
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):e128-e131. PubMed ID: 29555397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of dabigatran requiring hemodialysis, fresh frozen plasma, and 2 doses of idarucizumab in a patient with acute kidney injury.
    Sheikh-Taha M
    Am J Health Syst Pharm; 2019 Jan; 76(1):9-12. PubMed ID: 31381100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful dabigatran reversal after subdural hemorrhage using idarucizumab in a mobile stroke unit: A case report.
    Thirunavukkarasu S; Kalashyan H; Jickling G; Jeerakathil TJ; Jayaprakash HK; Buck BH; Shuaib A; Butcher K
    Medicine (Baltimore); 2020 May; 99(21):e20200. PubMed ID: 32481289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran.
    Sié P
    Drug Des Devel Ther; 2016; 10():1683-9. PubMed ID: 27274201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.
    Fang CW; Tsai YT; Chou PC; Chen HM; Lu CM; Tsao CR; Chen CL; Sun MC; Shih YS; Hsieh CY; Chen LA; Chen PL; Yeh JT; Li YH
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):815-820. PubMed ID: 30573284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe obscure gastrointestinal bleeding successfully treated with idarucizumab.
    Rodríguez de Santiago E; Sierra Morales M; Martínez González J
    Rev Esp Enferm Dig; 2018 Apr; 110(4):264-265. PubMed ID: 29368938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence Supporting Idarucizumab for the Reversal of Dabigatran.
    Pollack CV
    Am J Med; 2016 Nov; 129(11S):S73-S79. PubMed ID: 27568285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.